Sangeeta Goswami

Oncology
1515 Holcombe Blvd Unit 1374
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications

Improve the Efficacy of B7-H3-Targeting Antibody-Drug Conjugate DS-7300a in TP53-deficient Tumors by Inducing Ferroptosis.

Improve the Efficacy of B7-H3-Targeting Antibody-Drug Conjugate DS-7300a in TP53-deficient Tumors by Inducing Ferroptosis.

Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026

Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability.

Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability.

Journal: JCO precision oncology
Published: March 30, 2026

Evidence of Higgs Boson Inclusive Production at High Transverse Momentum Decaying to a Pair of b-Quarks with the ATLAS Detector.

Evidence of Higgs Boson Inclusive Production at High Transverse Momentum Decaying to a Pair of b-Quarks with the ATLAS Detector.

Journal: Physical review letters
Published: March 24, 2026

Combination of Measurements of CP Properties of Higgs Boson Interactions with Vector Bosons Using Proton-Proton Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Combination of Measurements of CP Properties of Higgs Boson Interactions with Vector Bosons Using Proton-Proton Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Journal: Physical review letters
Published: March 24, 2026

Influence of body composition on the efficacy of nivolumab plus ipilimumab for metastatic clear cell renal cell carcinoma.

Influence of body composition on the efficacy of nivolumab plus ipilimumab for metastatic clear cell renal cell carcinoma.

Journal: Journal for immunotherapy of cancer
Published: February 16, 2026

Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis.

Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis.

Journal: Oncogene
Published: February 05, 2026

Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma.

Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 07, 2026

Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancer.

Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancer.

Journal: bioRxiv : the preprint server for biology
Published: December 15, 2025

A transferable gut microbiota-bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response.

A transferable gut microbiota-bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response.

Journal: Nature materials
Published: November 15, 2025

Characterization of the Three-Flavor Composition of Cosmic Neutrinos with IceCube.

Characterization of the Three-Flavor Composition of Cosmic Neutrinos with IceCube.

Journal: Physical review letters
Published: October 28, 2025

Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tract.

Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tract.

Journal: Bladder cancer (Amsterdam, Netherlands)
Published: September 24, 2025

Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy.

Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy.

Journal: Science advances
Published: September 10, 2025
Showing 1-12 of 95

Last Updated: 09/26/2026